New Issue: Citi sells $5.56 million enhanced barrier digital securities on biotech ETFs

By Wendy Van Sickle

Columbus, Ohio, Feb. 10 – Citigroup Global Markets Holdings Inc. priced $5.56 million of 0% enhanced barrier digital securities due Feb. 14, 2025 linked to the worst performing of the SPDR S&P Biotech ETF and the iShares Biotechnology ETF, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will be guaranteed by Citigroup Inc.

If the final level of each asset is greater than or equal to 80% of its initial level, the payout at maturity will be par plus 37.66%.

If any asset falls by more than 20%, the payout will be par plus the return of the worst performing asset with full exposure to losses.

Citigroup Global Markets Inc. is the underwriter.

Issuer:	Citigroup Global Markets Holdings Inc.
Guarantor:	Citigroup Inc.
Issue:	Enhanced barrier digital securities
Underlying assets:	SPDR S&P Biotech ETF, iShares Biotechnology ETF
Amount:	$5,563,000
Maturity:	Feb. 14, 2025
Coupon:	0%
Price:	Par
Payout at maturity:	If the final level of each asset is greater than 80% of its initial level, par plus 37.66%; otherwise, 1% loss for every 1% decline of the worst performer from its initial level
Initial levels:	$131.64 for iShares, $93.25 for SPDR
Barrier levels:	$105.312 for iShares, $74.60 for SPDR; 80% of initial levels
Pricing date:	Feb. 7
Settlement date:	Feb. 14
Underwriter:	Citigroup Global Markets Inc.
Fees:	1.5%
Cusip:	17330AF31

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.